ABIOMED INC (ABMD)
US0036541003 - Common Stock
| MRQ (2022-9-30) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | 2019 (2019-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 182.34M | 132.82M | 232.70M | 192.30M | 121.00M | |||
| Marketable Securities | 638.04M | 625.79M | 351.00M | 250.80M | 370.70M | |||
| Receivables | 94.47M | 90.61M | 97.20M | 84.70M | 90.80M | |||
| Inventories | 102.24M | 93.98M | 81.10M | 90.10M | 80.90M | |||
| Other Current Assets | 45.71M | 33.28M | 26.00M | 18.00M | 13.70M | |||
| Total Current Assets | 1.06B | 976.47M | 788.00M | 635.90M | 677.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 202.71M | 212.01M | 203.20M | 176.70M | 145.00M | |||
| Investments And Advances | 289.06M | 351.94M | 365.70M | 302.20M | 102.50M | |||
| Goodwill | 72.96M | 76.79M | 78.60M | 32.00M | 32.60M | |||
| Intangibles | 50.13M | 45.64M | 47.50M | 22.60M | 15.20M | |||
| Other Non-Current Assets | 18.88M | 10.55M | 11.40M | 47.10M | 81.80M | |||
| Total Non-Current Assets | 633.75M | 696.92M | 706.40M | 580.60M | 377.10M | |||
| TOTAL ASSETS | 1.70B | 1.67B | 1.49B | 1.22B | 1.05B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 66.58M | 73.59M | 62.60M | 57.10M | 45.20M | |||
| Accounts Payable | 35.07M | 35.35M | 34.80M | 32.80M | 32.20M | |||
| Other Current Liabilities | 32.41M | 29.52M | 31.50M | 42.00M | 28.70M | |||
| Total Current Liabilities | 134.06M | 138.46M | 129.00M | 131.90M | 106.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 689.00K | 781.00K | 800.00K | 800.00K | 800.00K | |||
| Other Non-Current Liabilities | 22.01M | 30.83M | 34.90M | 18.30M | 10.60M | |||
| Total Non-Current Liabilities | 22.70M | 31.61M | 35.70M | 19.10M | 11.50M | |||
| TOTAL LIABILITIES | 156.76M | 170.07M | 164.70M | 151.00M | 117.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 1.13B | 964.51M | 828.00M | 602.50M | 399.50M | |||
| Additional Paid In Capital | 904.75M | 870.07M | 800.70M | 739.10M | 690.50M | |||
| Common Shares | 452.00K | 455.00K | 500.00K | 500.00K | 500.00K | |||
| Treasury Stock | -443.97M | -304.56M | -288.00M | -265.40M | -138.90M | |||
| Other Shareholders' Equity | -46.65M | -27.16M | -11.40M | -11.20M | -14.70M | |||
| Shares Outstanding | 45.17M | 45.55M | 45.30M | 45.00M | 45.10M | |||
| Tangible Book Value per Share | 31.36 | 30.32 | 26.57 | 22.46 | 19.71 | |||
| Total Shareholders' Equity | 1.54B | 1.50B | 1.33B | 1.07B | 936.90M | |||
| TOTAL LIABILITIES AND EQUITY | 1.70B | 1.67B | 1.49B | 1.22B | 1.05B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 7.93 | 7.05 | 6.11 | 4.82 | 6.39 | |||
| Return On Assets (ROA) | 15.72% | 8.16% | 15.09% | 16.69% | 24.57% | |||
| Return On Equity (ROE) | 17.32% | 9.08% | 16.96% | 19.05% | 27.64% | |||
| Return On Invested Capital (ROIC) | 12.85% | 13.21% | 13.28% | 18.15% | 18.73% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 27.05% | 26.12% | 23.20% | 30.69% | 38.89% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 32.43% | 31.01% | 27.67% | 33.54% | 43.44% | |||
All data in USD